Article and Video CATEGORIES
The second podcast from Dr. Ramalingam's excellent webinar on Personalizing Treatment for First Line NSCLC is the question and answer session that followed it, which includes many questions about EGFR-based therapy, antiangiogenic agents, and other relevant issues for individualized treatments for patients.
Here is the audio and video versions of the podcast, along with the figures and transcript for it.
[powerpress]
ramalingam-personalizing-first-line-nsclc-therapy-qa-transcript
ramalingam-personalizing-first-line-nsclc-therapy-qa-transcript
ramalingam-personalizing-first-line-nsclc-therapy-qa-figures
Many thanks to Dr. Ramalingam, who donated his time and effort rather than accept the offered honorarium, and to Eli Lilly Oncology for providing the educational grant that supported this webinar and podcast.
Please feel free to offer comments and raise questions in our
discussion forums.
Forum Discussions
Hi Revtoby, Welcome to Grace. I'm sorry you and your wife are worried about cancer but we couldn't say whether or not your wife's leison is cancer no matter how much...
Canyil, I'm sorry your father and you are going through this. While we can't give urgent help we are her to help offer info and resources to help make the best...
Hello and welcome to Grace. I'm sorry you're going through this worry. It is normal to watch a small very slow-growing solid nodule with once-a-year CT scans. Anything less than a...
Thanks you very much. So in summary the course of action taken suggested by lung specalist (re scan in 12 months) seems appropriate? And a PET at this stage is probably...
I can't say what is appropriate for you that's only something your professionals with all your information can do. However, when someone has a solid nodule less than a cm that...